A 32-year-old male labourer from rural Odisha presents to a primary health centre in July with a 5-day history of fever, chills, and headache. He reports working in paddy fields during the monsoon season. On examination, he is febrile (38.5°C), has mild hepatosplenomegaly, and appears acutely ill. A blood smear shows ring forms and trophozoites within RBCs. The patient is treated with chloroquine, but on day 3 of treatment, his fever persists and he develops severe headache with altered mental status. What is the most likely explanation for this clinical deterioration?

Explanation

## Clinical Reasoning This case presents a classic progression from uncomplicated malaria to a severe form with neurological complications. ### Key Clinical Features **Initial Presentation:** - Fever, chills, headache in a monsoon-season labourer from endemic region (Odisha) - Ring forms and trophozoites on blood smear (consistent with *Plasmodium* infection) - Mild hepatosplenomegaly (typical of malaria) **Deterioration Pattern:** - Persistent fever despite chloroquine therapy (day 3) - Severe headache with altered mental status (confusion, disorientation, or coma) - This is the hallmark of **cerebral malaria** ### Why This Is Cerebral Malaria **Key Point:** Cerebral malaria is the most common severe manifestation of *Plasmodium falciparum* malaria and is a medical emergency with mortality >15% even with treatment. **Clinical Pearl:** Chloroquine resistance in *P. falciparum* is widespread in India (particularly in endemic zones like Odisha), explaining both the persistent fever and the rapid progression to severe disease. The patient should have been started on artemisinin-based combination therapy (ACT) or quinine, not chloroquine monotherapy. **High-Yield:** Cerebral malaria criteria include: 1. Plasmodium-positive blood smear 2. Unrousable coma (Blantyre coma score ≤2) OR inability to localize pain 3. No other cause of coma ### Pathophysiology *P. falciparum* causes: - Sequestration of parasitized RBCs in cerebral microvasculature - Endothelial dysfunction and blood–brain barrier disruption - Cytokine-mediated inflammation (TNF-α, IL-6) - Impaired cerebral autoregulation **Mnemonic: SEVERE MALARIA = SAC** - **S**evere anaemia (Hb <7 g/dL) - **A**cute kidney injury - **C**erebral malaria (Also: acute respiratory distress, hypoglycaemia, lactic acidosis, pulmonary oedema, jaundice, shock) ### Management Implications - **Immediate:** IV artesunate (first-line for severe malaria globally) - Supportive care: manage seizures, maintain airway, correct hypoglycaemia - Avoid chloroquine; it is ineffective against *P. falciparum* in most endemic areas [cite:Park 26e Ch 10]